Promise Bio secures $8.3M in seed investment for immune-mediated diseases
Precision medicine startup Promise Bio announced that it has emerged from stealth with an $8.3 million seed investment.Awz Ventures led the round with funding from AION Lab’s venture seeding track from AstraZeneca and Pfizer,…
Continue Reading